Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

SYMBICORT 100 TURBUHALER 6 MCG

FORMOTEROL FUMARATE DIHYDRATE : 6 MCG BUDESONIDE : 100 MCG · DIN 02245385 · ASTRAZENECA CANADA INC

Health Canada status: MARKETED

What is SYMBICORT 100 TURBUHALER?

SYMBICORT 100 TURBUHALER 6 MCG contains FORMOTEROL FUMARATE DIHYDRATE : 6 MCG BUDESONIDE : 100 MCG. It is listed in the Health Canada Drug Product Database under DIN 02245385, held by ASTRAZENECA CANADA INC, supplied as POWDER for INHALATION administration. Health Canada currently lists it as marketed, status dated 08-Feb-2002. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

What is SYMBICORT 100 TURBUHALER used for?

Treatment of asthma in patients 12+ years; maintenance treatment of moderate to severe COPD (including chronic bronchitis and emphysema) in adults.

Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.

Product details and regulatory record

DIN02245385
Brand nameSYMBICORT 100 TURBUHALER
Generic / active ingredientFORMOTEROL FUMARATE DIHYDRATE : 6 MCG BUDESONIDE : 100 MCG
ManufacturerASTRAZENECA CANADA INC
Strength6 MCG
Dosage formPOWDER
Route of administrationINHALATION
SchedulePrescription
ATC codeR03AK07 FORMOTEROL AND BUDESONIDE
AHFS class12:12.08.12 ; 68:04.00
BiosimilarNo
Health Canada statusMARKETED
Status date08-Feb-2002
Original market date2002-02-08 00:00:00

How is it administered?

Asthma: Anti-inflammatory reliever, maintenance, or combination therapy. COPD: Maintenance treatment. Administered via oral inhalation. Titrate to lowest effective dose.

Included because it drives pack selection and wastage. Consult the monograph.

How is it stored and handled?

Not explicitly detailed in provided text (standard section header present but content truncated).

How is it supplied?

Not explicitly detailed in provided text (mentions Turbuhaler device).

Contraindications

Known hypersensitivity to budesonide, formoterol, or inhaled lactose.

Warnings and precautions

LABA monotherapy increases risk of serious asthma-related events. Risk of adrenal suppression, decreased bone mineral density, cataracts, glaucoma, and immunosuppression.

What can be used instead?

Other Canadian products sharing ATC code R03AK07 FORMOTEROL AND BUDESONIDE. 2 of 3 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
SYMBICORT 200 TURBUHALER200 MCGPOWDERASTRAZENECA CANADA INCMARKETEDDIN 02245386
SYMBICORT FORTE TURBUHALER12 MCGPOWDERASTRAZENECA CANADA INCAPPROVEDDIN 02248218

Who else supplies FORMOTEROL AND BUDESONIDE worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. FORMOTEROL AND BUDESONIDE appears in 62 registered pack listings across 10 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for SYMBICORT 100 TURBUHALER

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Health Canada Drug Product Database (DPD), DIN 02245385. Last reviewed 2026-09-09. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.